Gene: FKBP14
Official Full Name: FKBP prolyl isomerase 14provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the FK506-binding protein family of peptidyl-prolyl cis-trans isomerases. The encoded protein is found in the lumen of the endoplasmic reticulum, where it is thought to accelerate protein folding. Defects in this gene are a cause of a type of Ehlers-Danlos syndrome (EDS). Both a protein-coding variant and noncoding variants are transcribed from this gene. [provided by RefSeq, Mar 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20484 | FKBP14 Knockout cell line (HeLa) | Human | FKBP14 | 1:3~1:6 | Negative | Online Inquiry |
KO20485 | FKBP14 Knockout cell line (HCT 116) | Human | FKBP14 | 1:2~1:4 | Negative | Online Inquiry |
KO20486 | FKBP14 Knockout cell line (HEK293) | Human | FKBP14 | 1:3~1:6 | Negative | Online Inquiry |
KO20487 | FKBP14 Knockout cell line (A549) | Human | FKBP14 | 1:3~1:4 | Negative | Online Inquiry |
FKBP14 Gene Knockout Cell Lines are genetically modified cells that have had the FKBP14 gene, which encodes the protein FK506-binding protein 14, selectively disrupted. This product serves as a crucial tool in functional genomics, allowing researchers to investigate the role of FKBP14 in various biological processes, including protein folding, cellular stress responses, and signal transduction pathways. By knocking out this specific gene, scientists can elucidate its contributions to health and disease mechanisms, providing insight into potential therapeutic targets.
The primary function of FKBP14 Gene Knockout Cell Lines lies in their ability to mimic disease conditions, enabling the study of cellular behavior in a controlled environment. The mechanism of action involves the use of CRISPR-Cas9 technology or similar gene-editing techniques to induce precise mutations, resulting in the attenuation of FKBP14 expression. As a result, researchers can observe phenotypic changes in cell proliferation, apoptosis, and responsiveness to pharmacologic agents, which are imperative for drug discovery and development.
The scientific relevance of these knockout cell lines extends into various research domains, such as cancer biology, neurobiology, and metabolic diseases. They can be utilized in high-throughput screening assays, aiding researchers in identifying small molecules or biological agents that restore normal cellular functions. Furthermore, in clinical contexts, understanding FKBP14’s role could pave the way for new diagnostics and treatments for diseases where protein misfolding or cellular stress is implicated.
FKBP14 Gene Knockout Cell Lines hold several advantages over traditional methods of studying gene function. Unlike transient knockdown techniques that are often temporary and less stable, these knockout lines provide a consistent and reproducible platform for experiments. Additionally, their specificity allows for clearer interpretations of data, minimizing off-target effects common in other gene editing strategies.
For researchers and clinicians looking to deepen their understanding of proteostasis and its implications in human health, FKBP14 Gene Knockout Cell Lines represent a valuable resource that bridges basic science and clinical relevance. Our company specializes in providing high-quality, validated genetic models that are essential for contemporary biological research, backed by extensive expertise in molecular biology and cell line development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.